/Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase
Abstract
National Research Collaboration Programme, an NHS England and NIHR partnership (NIHR 127963) and Cure EB.